Rare Diseases Action Plan 2026: what it means for people living with trigeminal neuralgia
England’s Rare Diseases Action Plan 2026 is an important development for people living with rare conditions.
For people living with trigeminal neuralgia, the question is practical. Will the plan help patients receive a diagnosis sooner, reach specialist care faster and avoid years of uncertainty?
It could. However, that will depend on whether national policy leads to measurable improvements in patient care.
What is the Rare Diseases Action Plan 2026?
The Rare Diseases Action Plan 2026 forms part of the UK Rare Diseases Framework. It sets out how England intends to improve the lives of people living with rare conditions.
The plan continues to focus on faster diagnosis, greater awareness among healthcare professionals, better co-ordination of care and improved access to specialist services, treatment and medicines.
Trigeminal neuralgia is not specifically named in the plan. Even so, many of its priorities matter directly to people living with TN and other facial pain conditions.
Why rare disease policy matters for trigeminal neuralgia
Trigeminal neuralgia is a neurological pain condition affecting the trigeminal nerve, which carries sensation from the face to the brain.
Many patients describe sudden attacks of severe facial pain. These attacks can be triggered by speaking, eating, brushing teeth, washing the face, cold air or even a light breeze.
For some people, diagnosis takes too long. Some patients move between services before reaching a clinician with experience of facial pain disorders. Others may first receive treatment for dental problems or different conditions before trigeminal neuralgia is recognised.
That is why the plan’s focus on faster diagnosis matters.
Every delay can affect quality of life, work, education, family life and mental wellbeing.
Diagnosis is only the first step
Receiving a diagnosis matters, but diagnosis alone does not solve everything.
Many people living with TN continue to face challenges accessing appropriate support, pain management and specialist expertise.
The plan’s focus on better co-ordination of care is highly relevant. Trigeminal neuralgia care may involve GPs, neurologists, neurosurgeons, pain specialists, dentists, maxillofacial teams and other healthcare professionals.
When services communicate well, patients benefit. When they do not, people may be left repeating the same story while trying to manage severe pain.
Why rare neurological conditions must not be overlooked
Rare disease policy is often associated with genetic disorders and childhood conditions. However, many adults also live with rare neurological conditions that can affect every part of daily life.
The Neurological Alliance has highlighted that rare neurological conditions need proper recognition within rare disease policy. This matters for people living with severe facial pain, who may otherwise be overlooked in wider discussions about rare disease care.
Specialist care remains essential
The plan continues to recognise the importance of access to specialist care, treatment and medicines.
For trigeminal neuralgia, specialist expertise matters. Facial pain conditions are not interchangeable. TN, painful trigeminal neuropathy, persistent idiopathic facial pain, SUNCT and SUNA may require different approaches and different clinical expertise.
Patients need access to clinicians who understand those differences.
Improving access to specialist care is more than a policy aim. It has the potential to improve outcomes, reduce distress and improve quality of life.
Rare disease inequalities and trigeminal neuralgia
Health equity is one of the most important themes in rare disease policy.
People should not experience poorer outcomes because of where they live, their income, their background or their ability to navigate complex healthcare systems.
For people living with TN, inequalities can appear in several ways. Some patients travel long distances to access specialist services. Others face unclear referral routes, fragmented care or years of uncertainty before finding a clinician who understands the condition.
Reducing these inequalities must remain a priority.
What TNA UK wants to see
The publication of the plan is welcome. However, patients judge success by what changes in practice.
For people living with trigeminal neuralgia, progress means:
earlier recognition of symptoms; faster referral to appropriate specialists; improved access to pain management; better understanding of facial pain conditions across healthcare settings; and clearer pathways into specialist services.
These are practical goals. Together, they could make a meaningful difference to patients and families.
TNA UK view
TNA UK welcomes continued national attention on rare diseases and the challenges faced by patients.
The priorities identified in the 2026 plan reflect many of the concerns raised by people living with trigeminal neuralgia and facial pain.
We will continue to advocate for earlier diagnosis, improved awareness, better co-ordination of care and access to specialist expertise.
Policy matters because it shapes services. Patients live with the consequences when services fail.
The challenge now is to ensure that the ambitions set out in the plan become meaningful improvements for people living with trigeminal neuralgia and facial pain.
By Aneeta Prem, CEO, TNA UK 15 June 2026